Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Novel DMARD monotherapy in rheumatoid arthritis.

Moltó A, Dougados M.

Lancet. 2019 Jun 8;393(10188):2277-2278. doi: 10.1016/S0140-6736(19)30768-8. Epub 2019 Jun 6. No abstract available.

PMID:
31180015
2.

Comorbidities in spondyloarthritis including psoriatic arthritis.

Moltó A, Dougados M.

Best Pract Res Clin Rheumatol. 2018 Jun;32(3):390-400. doi: 10.1016/j.berh.2018.09.002. Epub 2018 Nov 15. Review.

PMID:
31171310
3.

Peripheral spondyloarthritis: Concept, diagnosis and treatment.

Molto A, Sieper J.

Best Pract Res Clin Rheumatol. 2018 Jun;32(3):357-368. doi: 10.1016/j.berh.2019.02.010. Epub 2019 Mar 2. Review.

PMID:
31171308
4.

Evaluation of concomitant peripheral arthritis in patients with recent onset axial spondyloarthritis: 5-year results from the DESIR cohort.

López-Medina C, Dougados M, Ruyssen-Witrand A, Moltó A.

Arthritis Res Ther. 2019 Jun 6;21(1):139. doi: 10.1186/s13075-019-1927-6.

5.

Impact of gut involvement in patients with high probability of early spondyloarthritis. Data from DESIR cohort.

Wendling D, Guillot X, Prati C, Miceli-Richard C, Molto A, Lories R, Dougados M.

J Rheumatol. 2019 Jun 1. pii: jrheum.181326. doi: 10.3899/jrheum.181326. [Epub ahead of print]

PMID:
31154418
6.

Peripheral manifestations in spondyloarthritis and their impact: an ancillary analysis of the ASAS-COMOSPA study.

López-Medina C, Moltó A, Dougados M.

J Rheumatol. 2019 Apr 15. pii: jrheum.181331. doi: 10.3899/jrheum.181331. [Epub ahead of print]

PMID:
30988127
7.

Is self-assessment by patients of disease activity acceptable over the long term in rheumatoid arthritis? A 3-year follow-up of 771 patients.

Gossec L, Fayet F, Soubrier M, Foissac F, Molto A, Richette P, Beauvais C, Ruyssen-Witrand A, Perdriger A, Chary-Valckenaere I, Mouterde G, Dernis E, Euller-Ziegler L, Flipo RM, Gilson M, Balandraud N, Mariette X, Pouplin S, Marhadour T, Schaeverbeke T, Sordet C, Dougados M.

Rheumatology (Oxford). 2019 Mar 26. pii: kez094. doi: 10.1093/rheumatology/kez094. [Epub ahead of print] No abstract available.

PMID:
30915463
8.

Evaluation of the predictive validity of the ASAS axial spondyloarthritis criteria in the DESIR cohort.

Meghnathi B, Saraux A, Dougados M, Moltó A.

Clin Exp Rheumatol. 2019 Mar 7. [Epub ahead of print]

PMID:
30873948
9.

Association of Diverticulitis with Prolonged Spondyloarthritis: An Analysis of the ASAS-COMOSPA International Cohort.

Derakhshan MH, Goodson NJ, Packham J, Sengupta R, Molto A, Marzo-Ortega H, Siebert S; BRITSpA and the ASAS-COMOSPA Investigators.

J Clin Med. 2019 Feb 26;8(3). pii: E281. doi: 10.3390/jcm8030281.

10.

Similar alteration for mental and physical aspects in health-related quality of life over 5 to 8 years in 1347 patients with early arthritis and early inflammatory back pain.

Puyraimond-Zemmour D, Granger B, Molto A, Gaujoux-Viala C, Guillemin F, Ruyssen-Witrand A, Dougados M, Fautrel B, Gossec L.

Arthritis Res Ther. 2019 Feb 19;21(1):63. doi: 10.1186/s13075-019-1841-y.

11.

Clinical Characteristics of Patients with Spondyloarthritis in Japan in Comparison with Other Regions of the World.

Kishimoto M, Yoshida K, Ichikawa N, Inoue H, Kaneko Y, Kawasaki T, Matsui K, Morita M, Suda M, Tada K, Takizawa N, Tamura N, Taniguchi A, Taniguchi Y, Tsuji S, Haji Y, Rokutanda R, Yanaoka H, Cheung PP, Gu J, Kim TH, Luo SF, Okada M, López Medina C, Molto A, Dougados M, Kobayashi S, van der Heijde D, Tomita T.

J Rheumatol. 2019 Feb 15. pii: jrheum.180412. doi: 10.3899/jrheum.180412. [Epub ahead of print]

PMID:
30770497
12.

Response to 'Everything we see is a perspective, not the truth' by Chattopadhyay et al.

Molto A, Sahuguet J, Fechtenbaum J, Etcheto A, López-Medina C, Richette P, Dougados M, Roux C, Briot K.

Ann Rheum Dis. 2019 Feb 13. pii: annrheumdis-2019-215131. doi: 10.1136/annrheumdis-2019-215131. [Epub ahead of print] No abstract available.

PMID:
30760473
13.

Assessment of the adherence to disease-modifying drugs in patients with chronic inflammatory rheumatic diseases: Results of a survey of 1594 patients.

López-Medina C, Moltó A, Gérald F, Dubremetz M, Grange L, Thibaud G, Charles B, Lafarge D, Beauvais C, Gossec L, Dougados M.

Joint Bone Spine. 2019 Feb 7. pii: S1297-319X(19)30020-X. doi: 10.1016/j.jbspin.2019.01.023. [Epub ahead of print]

PMID:
30738192
14.

Individual-level and country-level socioeconomic determinants of disease outcomes in SpA: multinational, cross-sectional study (ASAS-COMOSPA).

Putrik P, Ramiro S, Moltó A, Keszei AP, Norton S, Dougados M, van der Heijde D, Landewé RBM, Boonen A.

Ann Rheum Dis. 2019 Apr;78(4):486-493. doi: 10.1136/annrheumdis-2018-214259. Epub 2019 Jan 23.

PMID:
30674477
15.

Increased Risk of Hypertension Associated with Spondyloarthritis Disease Duration: Results from the ASAS-COMOSPA Study.

Derakhshan MH, Goodson NJ, Packham JC, Sengupta R, Molto A, Marzo-Ortega H, Siebert S; BRITSpA and COMOSPA Investigators.

J Rheumatol. 2019 Jan 15. pii: jrheum.180538. doi: 10.3899/jrheum.180538. [Epub ahead of print]

PMID:
30647169
16.

Clinical peripheral enthesitis in the DESIR prospective longitudinal axial spondyloarthritis cohort.

Nadon V, Moltó A, Etcheto A, Bessette L, Michou L, D'Agostino MA, Claudepierre P, Wendling D, Haraoui P, Dougados M.

Clin Exp Rheumatol. 2018 Dec 19. [Epub ahead of print]

PMID:
30620273
17.

Acute anterior uveitis in spondyloarthritis: a monocentric study of 301 patients.

Frantz C, Portier A, Etcheto A, Monnet D, Brezin A, Roure F, Elhai M, Burki V, Fabreguet I, Koumakis E, Payet J, Gossec L, Dougados M, Molto A.

Clin Exp Rheumatol. 2019 Jan-Feb;37(1):26-31. Epub 2018 Dec 19.

18.

Update on the epidemiology, risk factors, and disease outcomes of axial spondyloarthritis.

López-Medina C, Moltó A.

Best Pract Res Clin Rheumatol. 2018 Apr;32(2):241-253. doi: 10.1016/j.berh.2018.10.006. Epub 2018 Nov 16. Review.

PMID:
30527429
19.

Evaluation of the performance of extreme patient-reported outcomes as surrogate markers for fibromyalgia in axial spondyloarthritis.

Santos-Faria D, Dougados M, Gossec L, Perrot S, Moltó A.

Rheumatol Int. 2019 Jan;39(1):141-146. doi: 10.1007/s00296-018-4200-4. Epub 2018 Nov 9.

PMID:
30413924
20.

Low incidence of vertebral fractures in early spondyloarthritis: 5-year prospective data of the DESIR cohort.

Sahuguet J, Fechtenbaum J, Molto A, Etcheto A, López-Medina C, Richette P, Dougados M, Roux C, Briot K.

Ann Rheum Dis. 2019 Jan;78(1):60-65. doi: 10.1136/annrheumdis-2018-213922. Epub 2018 Nov 2.

PMID:
30389692
21.

Spinal radiographic progression in early axial Spondyloarthritis: Five-year results from the DESIR cohort.

Ramiro S, van der Heijde D, Sepriano A, van Lunteren M, Moltó A, Feydy A, d'Agostino MA, Loeuille D, Dougados M, Reijnierse M, Claudepierre P.

Arthritis Care Res (Hoboken). 2018 Oct 24. doi: 10.1002/acr.23796. [Epub ahead of print]

PMID:
30354022
22.

Recommendations for the assessment and optimization of adherence to disease-modifying drugs in chronic inflammatory rheumatic diseases: A process based on literature reviews and expert consensus.

Gossec L, Molto A, Romand X, Puyraimond-Zemmour D, Lavielle M, Beauvais C, Senbel E, Flipo RM, Pouplin S, Richez C, Saraux A, Mézières M, Gutermann L, Gaudin P, Wendling D, Dougados M.

Joint Bone Spine. 2019 Jan;86(1):13-19. doi: 10.1016/j.jbspin.2018.08.006. Epub 2018 Sep 19.

PMID:
30243782
23.

Detection of flares by decrease in physical activity, collected using wearable activity trackers, in rheumatoid arthritis or axial spondyloarthritis: an application of Machine-Learning analyses in rheumatology.

Gossec L, Guyard F, Leroy D, Lafargue T, Seiler M, Jacquemin C, Molto A, Sellam J, Foltz V, Gandjbakhch F, Hudry C, Mitrovic S, Fautrel B, Servy H.

Arthritis Care Res (Hoboken). 2018 Sep 22. doi: 10.1002/acr.23768. [Epub ahead of print]

PMID:
30242992
24.

Assessment of SpondyloArthritis International Society (ASAS) Consensus on Spanish Nomenclature for Spondyloarthritis.

Navarro-Compán V, Otón T, Loza E, Almodóvar R, Ariza-Ariza R, Bautista-Molano W, Burgos-Vargas R, Collantes-Estévez E, de Miguel E, González-Fernández C, Gratacós J, Ibáñez S, Juanola X, Maldonado-Cocco J, Moltó A, Mulero J, Pacheco-Tena C, Ramos-Remus C, Sanz-Sanz J, Valle-Oñate R, Zarco P, Marzo-Ortega H.

Reumatol Clin. 2018 Sep 4. pii: S1699-258X(18)30173-6. doi: 10.1016/j.reuma.2018.07.014. [Epub ahead of print] English, Spanish.

25.

Response to: "Diffuse Idiopathic Skeletal Hyperostosis and Ankylosing Spondylitis. Comment on the article by Latourte et al" by Olmedo-Garzón and Ruiz-Ollero.

Latourte A, Moltó A.

Arthritis Care Res (Hoboken). 2018 Sep 7. doi: 10.1002/acr.23744. [Epub ahead of print]

PMID:
30192080
26.

Evaluation of extreme patient-reported outcome in early spondyloarthritis and its impact on the effect of TNF-α blockers treatment.

Meghnathi B, Claudepierre P, Dougados M, Moltó A.

Clin Exp Rheumatol. 2018 Nov-Dec;36(6):1043-1048. Epub 2018 Aug 29.

PMID:
30183594
27.

Methods to improve medication adherence in patients with chronic inflammatory rheumatic diseases: a systematic literature review.

Lavielle M, Puyraimond-Zemmour D, Romand X, Gossec L, Senbel E, Pouplin S, Beauvais C, Gutermann L, Mezieres M, Dougados M, Molto A.

RMD Open. 2018 Jul 27;4(2):e000684. doi: 10.1136/rmdopen-2018-000684. eCollection 2018.

28.

Which scoring method depicts spinal radiographic damage in early axial spondyloarthritis best? Five-year results from the DESIR cohort.

Ramiro S, Claudepierre P, Sepriano A, van Lunteren M, Molto A, Feydy A, Antonietta d'Agostino M, Loeuille D, Dougados M, Reijnierse M, van der Heijde D.

Rheumatology (Oxford). 2018 Nov 1;57(11):1991-2000. doi: 10.1093/rheumatology/key185.

PMID:
30053219
29.

Work participation in spondyloarthritis across countries: analysis from the ASAS-COMOSPA study.

Rodrigues Manica S, Sepriano A, Ramiro S, Pimentel Santos F, Putrik P, Nikiphorou E, Norton S, Molto A, Dougados M, van der Heijde D, Landewé RBM, van den Bosch FE, Boonen A.

Ann Rheum Dis. 2018 Sep;77(9):1303-1310. doi: 10.1136/annrheumdis-2018-213464. Epub 2018 Jun 2.

PMID:
29860232
30.

Increase In Il-31 Serum Levels Is Associated With Reduced Structural Damage In Early Axial Spondyloarthritis.

Rosine N, Etcheto A, Hendel-Chavez H, Seror R, Briot K, Molto A, Chanson P, Taoufik Y, Wendling D, Lories R, Berenbaum F, van den Berg R, Claudepierre P, Feydy A, Dougados M, Roux C, Miceli-Richard C.

Sci Rep. 2018 May 16;8(1):7731. doi: 10.1038/s41598-018-25722-z.

31.

The Prevalence of Renal Impairment in Patients with Spondyloarthritis: Results from the International ASAS-COMOSPA Study.

Couderc M, Pereira B, Molto A, Tiple A, Soubrier M, Dougados M.

J Rheumatol. 2018 Jun;45(6):795-801. doi: 10.3899/jrheum.170133. Epub 2018 Apr 15.

PMID:
29657148
33.

Comorbidities in Spondyloarthritis.

Moltó A, Nikiphorou E.

Front Med (Lausanne). 2018 Mar 12;5:62. doi: 10.3389/fmed.2018.00062. eCollection 2018. Review.

34.

Improving the peer review skills of young rheumatologists and researchers in rheumatology: the EMEUNET Peer Review Mentoring Program.

Rodríguez-Carrio J, Putrik P, Sepriano A, Moltó A, Nikiphorou E, Gossec L, Kvien TK, Ramiro S.

RMD Open. 2018 Feb 16;4(1):e000619. doi: 10.1136/rmdopen-2017-000619. eCollection 2018. Review.

35.

Adherence to recommendations for the use of anti-tumour necrosis factor and its impact over 5 years of follow-up in axial spondyloarthritis.

López-Medina C, Dougados M, Collantes-Estévez E, Moltó A.

Rheumatology (Oxford). 2018 May 1;57(5):880-890. doi: 10.1093/rheumatology/kex514.

PMID:
29474666
36.

Immunogenicity and persistence of a prime-boost re-vaccination strategy for pneumococcal vaccines in patients with rheumatoid arthritis.

Bahuaud M, Beaudouin-Bazire C, Husson M, Molto A, Launay O, Batteux F, Dougados M.

Hum Vaccin Immunother. 2018 Jun 3;14(6):1464-1470. doi: 10.1080/21645515.2018.1438091. Epub 2018 Apr 9.

37.

2018 update of French Society for Rheumatology (SFR) recommendations about the everyday management of patients with spondyloarthritis.

Wendling D, Lukas C, Prati C, Claudepierre P, Gossec L, Goupille P, Hudry C, Miceli-Richard C, Molto A, Pham T, Saraux A, Dougados M.

Joint Bone Spine. 2018 May;85(3):275-284. doi: 10.1016/j.jbspin.2018.01.006. Epub 2018 Mar 8.

PMID:
29407043
38.

Physical Activity Assessment Using an Activity Tracker in Patients with Rheumatoid Arthritis and Axial Spondyloarthritis: Prospective Observational Study.

Jacquemin C, Servy H, Molto A, Sellam J, Foltz V, Gandjbakhch F, Hudry C, Mitrovic S, Fautrel B, Gossec L.

JMIR Mhealth Uhealth. 2018 Jan 2;6(1):e1. doi: 10.2196/mhealth.7948.

39.

Prevalence of Comorbidities and Risk Factors for Comorbidities in Patients with Spondyloarthritis in Latin America: A Comparative Study with the General Population and Data from the ASAS-COMOSPA Study.

Bautista-Molano W, Landewé R, Burgos-Vargas R, Maldonado-Cocco J, Moltó A, van den Bosch F, Valle-Oñate R, Dougados M, van der Heijde D.

J Rheumatol. 2018 Feb;45(2):206-212. doi: 10.3899/jrheum.170520. Epub 2017 Dec 15.

PMID:
29247152
40.

Inequity in biological DMARD prescription for spondyloarthritis across the globe: results from the ASAS-COMOSPA study.

Nikiphorou E, van der Heijde D, Norton S, Landewé RB, Molto A, Dougados M, Van den Bosch FE, Ramiro S.

Ann Rheum Dis. 2018 Mar;77(3):405-411. doi: 10.1136/annrheumdis-2017-212457. Epub 2017 Dec 8.

PMID:
29222349
41.

Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers' effectiveness in axial spondyloarthritis: results of a prospective, multicentre study.

Moltó A, Etcheto A, Gossec L, Boudersa N, Claudepierre P, Roux N, Lemeunier L, Martin A, Sparsa L, Coquerelle P, Soubrier M, Perrot S, Dougados M.

Ann Rheum Dis. 2018 Apr;77(4):533-540. doi: 10.1136/annrheumdis-2017-212378. Epub 2017 Nov 28.

PMID:
29183878
42.

Answer to the letter to the editor regarding the article: "Determinants of short term fracture risk in patients with a recent history of low-trauma non-vertebral fracture".

Deloumeau A, Molto A, Roux C, Briot K.

Bone. 2018 Feb;107:229-230. doi: 10.1016/j.bone.2017.11.008. Epub 2017 Nov 16. No abstract available.

PMID:
29155245
43.

Vitamin D status in spondyloarthritis: results of the ASAS-COMOSPA international study.

Fernandes S, Etcheto A, van der Heijde D, Landewé R, van den Bosch F, Dougados M, Moltó A.

Clin Exp Rheumatol. 2018 Mar-Apr;36(2):210-214. Epub 2017 Nov 16.

44.

Association of Comorbidities in Spondyloarthritis With Poor Function, Work Disability, and Quality of Life: Results From the Assessment of SpondyloArthritis International Society Comorbidities in Spondyloarthritis Study.

Nikiphorou E, Ramiro S, van der Heijde D, Norton S, Moltó A, Dougados M, van den Bosch F, Landewé R; Assessment of SpondyloArthritis International Society Comorbidities in Spondyloarthritis Study Task Force.

Arthritis Care Res (Hoboken). 2018 Aug;70(8):1257-1262. doi: 10.1002/acr.23468. Epub 2018 Jun 28.

PMID:
29125900
45.

Systematic switch from innovator infliximab to biosimilar infliximab in inflammatory chronic diseases in daily clinical practice: The experience of Cochin University Hospital, Paris, France.

Avouac J, Moltó A, Abitbol V, Etcheto A, Salcion A, Gutermann L, Klotz C, Elhai M, Cohen P, Soret PA, Morin F, Conort O, Chast F, Goulvestre C, Jeunne CL, Chaussade S, Kahan A, Roux C, Allanore Y, Dougados M.

Semin Arthritis Rheum. 2018 Apr;47(5):741-748. doi: 10.1016/j.semarthrit.2017.10.002. Epub 2017 Oct 5.

PMID:
29102156
46.

The revised Bristol Rheumatoid Arthritis Fatigue measures and the Rheumatoid Arthritis Impact of Disease scale: validation in six countries.

Hewlett S, Kirwan J, Bode C, Cramp F, Carmona L, Dures E, Englbrecht M, Fransen J, Greenwood R, Hagel S, van de Laar M, Molto A, Nicklin J, Petersson IF, Redondo M, Schett G, Gossec L.

Rheumatology (Oxford). 2018 Feb 1;57(2):300-308. doi: 10.1093/rheumatology/kex370.

47.

An Assessment in SpondyloArthritis International Society (ASAS)-endorsed definition of clinically important worsening in axial spondyloarthritis based on ASDAS.

Molto A, Gossec L, Meghnathi B, Landewé RBM, van der Heijde D, Atagunduz P, Elzorkany BK, Akkoc N, Kiltz U, Gu J, Wei JCC, Dougados M; ASAS-FLARE study group.

Ann Rheum Dis. 2018 Jan;77(1):124-127. doi: 10.1136/annrheumdis-2017-212178. Epub 2017 Oct 16.

PMID:
29038299
48.

Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study.

Mariette X, Förger F, Abraham B, Flynn AD, Moltó A, Flipo RM, van Tubergen A, Shaughnessy L, Simpson J, Teil M, Helmer E, Wang M, Chakravarty EF.

Ann Rheum Dis. 2018 Feb;77(2):228-233. doi: 10.1136/annrheumdis-2017-212196. Epub 2017 Oct 13.

49.

Evaluation of the change in structural radiographic sacroiliac joint damage after 2 years of etanercept therapy (EMBARK trial) in comparison to a contemporary control cohort (DESIR cohort) in recent onset axial spondyloarthritis.

Dougados M, Maksymowych WP, Landewé RBM, Moltó A, Claudepierre P, de Hooge M, Lambert RG, Bonin R, Bukowski JF, Jones HE, Logeart I, Pedersen R, Szumski A, Vlahos B, van der Heijde D.

Ann Rheum Dis. 2018 Feb;77(2):221-227. doi: 10.1136/annrheumdis-2017-212008. Epub 2017 Sep 29.

50.

Flares assessed weekly in patients with rheumatoid arthritis or axial spondyloarthritis and relationship with physical activity measured using a connected activity tracker: a 3-month study.

Jacquemin C, Molto A, Servy H, Sellam J, Foltz V, Gandjbakhch F, Hudry C, Mitrovic S, Granger B, Fautrel B, Gossec L.

RMD Open. 2017 Jun 29;3(1):e000434. doi: 10.1136/rmdopen-2017-000434. eCollection 2017.

Supplemental Content

Support Center